Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages.

समान संसाधन

• SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms.
  द्वारा: Yahi, N, और अन्य
  प्रकाशित: (1995)
• Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line.
  द्वारा: Yahi, N, और अन्य
  प्रकाशित: (1995)
• Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides.
  द्वारा: Vives, E, और अन्य
  प्रकाशित: (1994)
• Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells.
  द्वारा: Fantini, J, और अन्य
  प्रकाशित: (1991)
• Human colon epithelial cells productively infected with human immunodeficiency virus show impaired differentiation and altered secretion.
  द्वारा: Fantini, J, और अन्य
  प्रकाशित: (1992)